Stockscreener 앱 받기
241.58
0.55%
-1.33
시간 외 거래:
241.58
Natera Inc 주식(NTRA)의 최신 뉴스
iA Global Asset Management Inc. Acquires Shares of 6,659 Natera, Inc. $NTRA - MarketBeat
GDS Wealth Management Has $11.61 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Is It Too Late To Consider Natera (NTRA) After A 4x Three Year Share Price Surge - Yahoo Finance
How Natera Inc. (NTRA) Affects Rotational Strategy Timing - Stock Traders Daily
How Investors May Respond To Natera (NTRA) MRD Breakthrough, AI Push And 2025 Revenue Outlook - simplywall.st
Fesko John, president at Natera, sells $4.2 million in NTRA stock By Investing.com - Investing.com India
Fesko John, president at Natera, sells $4.2 million in NTRA stock - Investing.com India
Lack of Natera (NTRA) Exposure Weighs on Mid-Cap Fund Performance - Insider Monkey
Lack of Natera (NTRA) Exposure Weighs on Voya MidCap Opportunities Fund Performance - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Buys 19,166 Shares of Natera, Inc. $NTRA - MarketBeat
Allstate Corp Makes New $775,000 Investment in Natera, Inc. $NTRA - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 339 Shares - MarketBeat
Solomon Moshkevich Sells 293 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CEO Chapman sells $17.2 million in shares - Investing.com
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 1,590 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 71,932 Shares - MarketBeat
Solomon Moshkevich Sells 23,205 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 17,806 Shares - MarketBeat
Natera CFO Brophy sells $14.6 million in NTRA stock By Investing.com - Investing.com UK
Natera CFO Brophy sells $14.6 million in NTRA stock - Investing.com
Natera CEO Chapman sells $17.2 million in shares By Investing.com - Investing.com UK
Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock By Investing.com - Investing.com Nigeria
Natera president sells $5.5 million in NTRA stock By Investing.com - Investing.com Nigeria
Natera co-founder Sheena Jonathan sells $1.44m in NTRA stock - Investing.com UK
Natera’s sec. Daniel Rabinowitz sells $4.6m in NTRA stock - Investing.com
Natera president sells $5.5 million in NTRA stock - Investing.com
Natera Executives and Director Engage in Significant Stock Transactions - TradingView
Natera Expands MRD Ambitions With Latitude Study And AI NVIDIA Deal - simplywall.st
Aubrey Capital Management Ltd Takes $2.61 Million Position in Natera, Inc. $NTRA - MarketBeat
Rakuten Investment Management Inc. Acquires New Position in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Unveils Promising Study Results for Colorectal Can - GuruFocus
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer - Yahoo Finance
Natera to present EXPAND trial data on fetal genetic screening By Investing.com - Investing.com India
Natera (NTRA) Surged as Results Beat Expectations - Insider Monkey
Natera to present EXPAND trial data on fetal genetic screening - Investing.com
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting - Yahoo Finance
Campbell & CO Investment Adviser LLC Acquires Shares of 5,145 Natera, Inc. $NTRA - MarketBeat
Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin - MSN
Massachusetts Financial Services Co. MA Sells 17,498 Shares of Natera, Inc. $NTRA - MarketBeat
Assessing Natera (NTRA) Valuation After AI Oncology Advances And Strong 2025 Growth Guidance - simplywall.st
Short Interest in Natera, Inc. (NASDAQ:NTRA) Rises By 39.8% - MarketBeat
Natera prenatal test false advertising $8.25M class action settlement explained: Are you owed money? - Claim Depot
AI-Enhanced Signatera Upgrade And NVIDIA Deal Could Be A Game Changer For Natera (NTRA) - simplywall.st
Is It Too Late To Consider Natera (NTRA) After Its Strong 1-Year Share Price Run? - simplywall.st
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Sumitomo Mitsui Trust Group Inc. Sells 88,968 Shares of Natera, Inc. $NTRA - MarketBeat
Assessing Whether Natera (NTRA) Is Overvalued After Strong Longer Term Share Price Gains - Yahoo Finance
Natera unveils AI model to enhance cancer recurrence risk assessment By Investing.com - Investing.com Nigeria
How Investors Are Reacting To Natera (NTRA) NVIDIA-Backed Multimodal AI And Precision Diagnostics Advances - Yahoo Finance
NTRA & NVDA Partner to Improve AI Models for Precision Medicine - sharewise.com
Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing - TipRanks
Natera, Inc. Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling - marketscreener.com
Natera unveils AI model to enhance cancer recurrence risk assessment - Investing.com
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling - Business Wire
Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating - TipRanks
(NTRA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
JP Morgan lifts Natera, Inc. (NTRA) target on Signatera momentum - MSN
Natera’s updated prenatal test now includes Gaucher disease - Gaucher Disease News
2.58%
자본화:
|
볼륨(24시간):